Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy

Journal of Interferon and Cytokine Research

Volumn 19, Issue 9, 1999, Pages 999-1004

  Sakai, Toshiaki ^a   Inoue, Atsushi ^a   Koh, Chang Sung ^a   Osame, Mitsuhiro ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SPINAL CORD DISEASE; VIRUS INFECTION;

ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIGANDS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PARAPARESIS, TROPICAL SPASTIC; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0032876202     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313208     Document Type: Article

References (32)

1. MARTIN, R., McFARLAND, H.F., and McFARLIN, D.E. (1992). Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10, 153-187.
2. OSAME, M., MATSUMOTO, M., USUKU, K., OSAME, M., IZUMO, S., IJICHI, N., AMITANI, H., TARA, M., and IGATA, A. (1987). Chronic progressive myelopathy associated with elevated antibodies to human T lymphotropic virus type I and adult T-cell leukemia like cells. Ann. Neurol. 21, 117-122.
3. LEHKY, T.J., FOX, C.H., KOENIG. S., LEVIN, M.C., FLERLAGE, N., IZUMO, S., SATO, E., RAINE, C.S., OSAME, M., and JACOBSON, S. (1995). Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann. Neurol. 37, 167-175.
4. GRIFFITH, T.G., and FERGUSON, T.A. (1997). The role of FasL-induced apoptosis in immune privilege. Immunol. Today 18, 240-244.
5. RAFF, M.C., BARRES, B.A., BURNE, J.F., COLES, H.S., ISHIZAKI, Y., and JACOBSON, M.D. (1993). Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262, 695-700.
6. ICHIKAWA, H., OTA, K., and IWATA, M. (1996). Increased Fas antigen on T cells in multiple sclerosis. J. Neuroimmunol. 71, 125-129.
7. WATANABE-FUKUNAGA, R., BRANNAN, C.I., ITOH, N., YONEHARA, S., COPELAND, N.G., JENKINS, N.A., and NAGATA, S. (1992). The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274-1279.
8. SUDA, T., TAKAHASHI, T., GOLSTEIN, P., and NAGATA, S. (1993). Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169-1178.
9. SUDA, T., OKAZAKJ, T., NAITO, Y., YOKOTA, T., ARAI, N., OZAKI, S., NAKAO, K., and NAGATA, S. (1995). Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154, 3806-3813.
10. ARASE. H., ARASE, N., and SAITO, T. (1995). Fas mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181, 1235-1238.
11. TANAKA, M., SUDA, T., TAKAHASHI, T., and NAGATA. S, (1995). Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14, 1129-1135.
12. GRUSS, H.-J., and DOWER, S. (1995). Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphoma. Blood 85, 3378-3404.
13. NAGATA, S., and SUDA, T. (1995;. Fas and Fas ligand: 1pr and gld mutations. Immunol. Today 16, 39-43.
14. VAUX, D.L. (1993). Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA 90, 786-789.
15. JACOBSON, M.D., BURNE, J.F., KING, M.P., MIYASHITA, T., REED, J.C., and RAFF, M.C. (1993). Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361, 365-369.
16. TSUJIMOTI, Y. (1989). Stress-resistance conferred by high level of bcl-2a protein in human B lymphoblastoid cell. Oncogene 4, 1331-1336.
17. PENDER. M.P., McCOMBE. P.A., YOUNG, G., and NGUYEN, K.B. (1992). Apoptosis of T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance. J. Autoimmun. 5,401-410.
18. POSER, C.M., PATY, D.W., SCHEINBERG, L., McDONALD, I., DAVIS, F.A., and EBERS, G.C. (1983). New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann, Neurol. 13, 227-231.
19. OEHM, A., BEHRMANN, I., FALK, W., PAWLITA, M., MAIER, G., KLAS, C., LI-WEBER, M., RICHARDS, S., DHEIN, J., TRAUTH, B.C., PONSTINGI, H., and KRAMMER, P.H. (1992). Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267, 10709-10715.
20. NAGATA, S., and GOLSTEIN, P. (1995). The Fas death factor. Science 267, 1449-1456.
21. SMITH, C.A., FARRAH, T., and GOODWIN, R.G. (1994). The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959-962.
22. YONEHARA, S., ISHII, A.M., and YONEHARA, A. (1989). Cell killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.
23. TAKAHASHI, T., TANAKA, M., BRANNAN, C.I., JENKINS, N.A., COPELAND, N.G., SUDA, T., and NAGATA, S. (1994). Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76, 969-976.
24. WATANABE-FUKUNAGA, R., BRANNAN, C.I., COPELAND, N.G., JENKINS, N.A., and NAGATA, S. (1992). Lymphoprolif eration disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
25. TANAKA, M., SUDA, T., HAZE, K., NAKAMURA, N., SATO, K., KIMURA. F., MOTOYOSHI, K., MIZUKI, M., TAGAWA, S., OHGA, S., HATAKE, K., DRUMMOND, A.M., and NAGATA, S. (1996). Fas ligand in human serum. Nature Med. 2, 317-322.
26. KATSIKIS P.D., WUNDERLICH, E.S., SMITH, C.A., HERZENBERG, L.A., and HERZENBERG, L.A. (1995). Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181, 2029-2036.
27. NUNEZ. G., MERINO, R., GRILLOT, D., and GONZALEZGARCIA, M. (1994). Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival. Immunol. Today 15, 582-588.
28. NGUYEN, K.B., McCOMBE, P.A., and PENDER, M.P. (1997). Increased apoptosis of T lymphocytes and macrophages in the central and peripheral nervous systems of Lewis rats with experimental autoimmune encephalomyelitis treated with dexamathasone. J. Neuropathol. Exp. Neural. 56, 58-69.
29. WHITE, C.A., McCOMBE, P.A., and PENDER, M.P. (1998). The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 82, 47-55.
30. CIUSANI, E., FRIGERIO, S., GELATI, M., CORSINI, E., DUFOUR, A., NESPOLO, A., LA MANTIA, L., MILANESE, C., MASSA, G., and SALMAGGI, A. (1998). Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 82, 5-12.
31. ZIPP, F., WELLER, M., CALABRESI, P.A., FRANK, J.A., BASH, C.N., DICHGANS, J., McFARLAND, H.F., and MARTIN, R. (1998). Increased serum levels of soluble CD95 (Apo-1/Fas) in relapsing-remitting multiple sclerosis. Ann. Neurol. 43, 116-120.
32. DEBATIN, K.M., GOLDMAN, C.K., BAMFORD, R., WALDMANN, T.A., and KRAMMER, P.H. (1990). Monoclonal antibody-mediated apoptosis in adult T-cell leukemia. Lancet 335, 497-500.